AIM · AIM ImmunoTech Inc. · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred losses from operations and operating cash outflows exceeded cash inflows from operating activities for the six months ended June 30, 2026. These conditions raise substantial doubt regarding the Company's ability to continue as a going concern for a period of at least one year from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 7, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-17 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
24,000 |
| 2026-09-16 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
11,000 |
| 2026-09-15 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
22,000 |
| 2026-09-14 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
5,900 |
| 2026-03-12 | Equels Thomas K |
Director, CEO & President |
Other↑
|
Common stock
|
25,000 |
| 2026-03-12 | Equels Thomas K |
Director, CEO & President |
Other↓
Filing footnotes — Series G Convertible Preferred Stock (Direct)
The Preferred shares are convertible into common stock at a rate of 1,000 shares of common stock per whole perferred share, effectively $1.00 per share of common stock. None |
Series G Convertible Preferred Stock
|
25 |
| 2026-03-12 | CHEMEROW DAVID I. |
Director |
Other↑
|
Common Stock
|
25,000 |
| 2026-03-12 | CHEMEROW DAVID I. |
Director |
Other↓
Filing footnotes — Series G Convertible Prefered Stock (Direct)
The preferred shares are convertible into common stock at a rate of 1,000 shares of common stock per whole preferred share, effectively $1.00 per share of common stock. None |
Series G Convertible Prefered Stock
|
25 |
| 2026-03-06 | Equels Thomas K |
Director, CEO & President |
Other↑
Filing footnotes — Series G Convertible Preferred Stock (Direct)
Each share has a stated value of $1,000 and is convertible into 1,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. n/a - Preferred shares are perpetual. |
Series G Convertible Preferred Stock
|
25 |
| 2026-03-06 | Equels Thomas K |
Director, CEO & President |
Other↑
Filing footnotes — Class G Warrants (Direct)
Each warrant is exercisable for one share of common stock at an exercise price of $1.00 per share and was issued as part of a subscription right issued in a rights offering. |
Class G Warrants
|
50,000 |
| 2026-03-06 | CHEMEROW DAVID I. |
Director |
Other↑
Filing footnotes — Class G Warrants (Direct)
Each warrant is exercisable for one share of common stock at an exercise price of $1.00 per share and was issued as part of a subscription right issued in a rights offering. |
Class G Warrants
|
50,000 |
| 2026-03-06 | CHEMEROW DAVID I. |
Director |
Other↑
Filing footnotes — Series G Convertible Preferred Stock (Direct)
Each share has a stated value of $1,000 and is convertible into 1,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. n/a - Preferred shares are perpetual. |
Series G Convertible Preferred Stock
|
25 |
| 2026-02-05 | CHEMEROW DAVID I. |
Director |
Award↑
|
Common Stock
(I)
|
2,800 |
| 2025-06-13 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
107 |
| 2025-06-12 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
103 |
| 2025-04-11 | MITCHELL WILLIAM M |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025. |
Common Stock
|
196,851 |
| 2025-04-11 | KELLNER TED D |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025. |
Common Stock
|
1,968,504 |
| 2025-04-11 | Equels Thomas K |
Director, CEO & President |
Buy↑
Filing footnotes — Common Stock (Direct)
Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025. |
Common Stock
|
1,968,504 |
| 2025-04-04 | Rodino Peter W III |
COO, Secretary, Gen. Counsel |
Buy↑
|
Common Stock
|
500 |
| 2025-04-04 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
41,000 |
| 2025-03-14 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
44,899 |
| 2025-03-14 | CHEMEROW DAVID I. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
44,899 |
| 2025-03-14 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
44,899 |
| 2025-03-05 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
50,000 |
| 2025-03-04 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
83,334 |
| 2025-03-04 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
44,000 |
| 2025-02-28 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
38,580 |
| 2025-02-28 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
38,580 |
| 2025-02-28 | CHEMEROW DAVID I. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
19,290 |
| 2025-02-14 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
43,330 |
| 2025-02-14 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
43,330 |
| 2025-01-31 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
25,797 |
| 2025-01-31 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
25,797 |
| 2025-01-15 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
27,412 |
| 2025-01-15 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
27,412 |
| 2024-12-31 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
26,305 |
| 2024-12-31 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
26,305 |
| 2024-12-31 | APPELROUTH STEWART |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
8,768 |
| 2024-12-19 | MITCHELL WILLIAM M |
Director |
Sell↓
|
Common Stock
|
4,580 |
| 2024-12-18 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
22,727 |
| 2024-12-13 | APPELROUTH STEWART |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
24,452 |
| 2024-12-13 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
24,452 |
| 2024-12-13 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
24,452 |
| 2024-12-02 | APPELROUTH STEWART |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The reporting person did not intend this purchase. |
Common Stock
|
1 |
| 2024-12-02 | APPELROUTH STEWART |
Director |
Buy↑
|
Common Stock
|
11,111 |
| 2024-12-02 | APPELROUTH STEWART |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
22,645 |
| 2024-12-02 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
22,645 |
| 2024-12-02 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
22,645 |
| 2024-11-21 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
20,000 |
| 2024-11-20 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
60,110 |